Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension

被引:39
作者
Sakata, K
Shirotani, M
Yoshida, H
Urano, T
Takada, Y
Takada, A
机构
[1] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 43131, Japan
[3] Hamamatsu Univ Sch Med, Dept Pathophysiol, Hamamatsu, Shizuoka 43131, Japan
关键词
D O I
10.1016/S0002-8703(99)70368-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Impaired fibrinolysis is associated with thromboembolic complications in hypertensive patients. It has been reported that cardiovascular morbidity and mortality rates are high even after lowering the elevated blood pressure with antihypertensive drugs. The aim of this study was to assess the effect of clinically used dosages of enalapril and nitrendipine on the fibrinolytic system. Methods Tissue plasminogen activator antigen (tPA) and tissue plasminogen activator inhibitor-1 (PAI-1) activity were measured in 20 normotensive male subjects and 46 male patients with mild essential hypertension divided into 2 groups (22 patients treated with 5 to 10 mg enalapril once a day and 24 treated with 5 to 10 mg nitrendipine once a day) before and 3 months after drug administration. Plasma renin activity and norepinephrine concentration were also measured. Results There were no significant differences in basal characteristics between the 2 hypertensive groups. In both hypertensive groups, blood pressure was significantly reduced to a similar level after drug treatment, In the 2 hypertensive groups, plasma renin activity significantly increased after drug treatment; however, there were no significant changes in norepinephrine concentration. Before drug treatment, the 2 hypertensive groups had significantly higher IPA and higher PAI-1 activity than the normotensive subjects. In the enalapril group, there was no significant change in IPA although PAI-1 activity significantly decreased after drug treatment. In the nitrendipine group, there was no significant change in tPA although PAI-1 activity significantly increased after drug treatment. Conclusion Thus enalapril improved impaired fibrinolysis but nitrendipine further aggravated Fibrinolysis in essential hypertension. Considering the effect of antihypertensive drugs on the fibrinolytic system, more effective and beneficial treatment of hypertensives, especially at a high risk for thrombus formation might be selected.
引用
收藏
页码:1094 / 1099
页数:6
相关论文
共 39 条
[11]   APPLICATION OF A RADIOIMMUNOASSAY FOR ANGIOTENSIN I TO PHYSIOLOGIC MEASUREMENTS OF PLASMA RENIN ACTIVITY IN NORMAL HUMAN SUBJECTS [J].
HABER, E ;
KOERNER, T ;
PAGE, LB ;
KLIMAN, B ;
PURNODE, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (10) :1349-+
[12]   Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol - Results from the angina prognosis study in Stockholm [J].
Held, C ;
Hjemdahl, P ;
Rehnqvist, N ;
Wallen, H ;
Bjorkander, I ;
Eriksson, SV ;
Forslund, L ;
Wiman, B .
CIRCULATION, 1997, 95 (10) :2380-2386
[13]   CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J].
HELD, PH ;
YUSUF, S ;
FURBERG, CD .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709) :1187-1192
[14]   PREDICTIVE VALUE OF TISSUE-PLASMINOGEN ACTIVATOR MASS CONCENTRATION ON LONG-TERM MORTALITY IN PATIENTS WITH CORONARY-ARTERY DISEASE - A 7-YEAR FOLLOW-UP [J].
JANSSON, JH ;
OLOFSSON, BO ;
NILSSON, TK .
CIRCULATION, 1993, 88 (05) :2030-2034
[15]  
JANSSON JH, 1991, J INTERN MED, V229, P229
[16]   ANGIOTENSIN INDUCTION OF PAI-1 EXPRESSION IN ENDOTHELIAL-CELLS IS MEDIATED BY THE HEXAPEPTIDE ANGIOTENSIN-IV [J].
KERINS, DM ;
HAO, Q ;
VAUGHN, DE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2515-2520
[17]   THE EFFECT OF ENALAPRIL ON MORTAL AND MORBID EVENTS IN PATIENTS WITH HYPERTENSION AND LEFT-VENTRICULAR DYSFUNCTION [J].
KOSTIS, JB .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (09) :909-914
[18]  
MACMURRAY J, 1997, LANCET, V349, P585
[19]   The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction [J].
Oshima, S ;
Ogawa, H ;
Mizuno, Y ;
Yamashita, S ;
Noda, K ;
Saito, T ;
Sumida, H ;
Suefuji, H ;
Kaikita, K ;
Soejima, H ;
Yasue, H .
AMERICAN HEART JOURNAL, 1997, 134 (05) :961-966
[20]   Effect of amlodipine on morbidity and mortality in severe chronic heart failure [J].
Packer, M ;
OConnor, CM ;
Ghali, JK ;
Pressler, ML ;
Carson, PE ;
Belkin, RN ;
Miller, AB ;
Neuberg, GW ;
Frid, D ;
Wertheimer, JH ;
Cropp, AB ;
DeMets, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1107-1114